All these results indicated that ANXA2 increased the expression of GPC1 via c-Myc and that the upregulated GPC1 further promoted the c-Myc level, forming a positive feedback loop, which eventually led to enhanced proliferation of glioma cells. Here, MYC is linked to central nervous system cancer.